Is Albemarle stock a Buy, Sell or Hold?
Albemarle stock has received a consensus rating of buy. The average rating score is and is based on 29 buy ratings, 20 hold ratings, and 10 sell ratings.What was the 52-week low for Albemarle stock?
The low in the last 52 weeks of Albemarle stock was 185.15. According to the current price, Albemarle is 112.61% away from the 52-week low.What was the 52-week high for Albemarle stock?
The high in the last 52 weeks of Albemarle stock was 334.25. According to the current price, Albemarle is 62.38% away from the 52-week high.What are analysts forecasts for Albemarle stock?
The 59 analysts offering price forecasts for Albemarle have a median target of 279.29, with a high estimate of 498.00 and a low estimate of 80.00. The median estimate represents a 74.65 difference from the last price of 208.49.Albemarle Stock Snapshot
208.37
Bid
400.00
Bid Size
208.38
Ask
600.00
Ask Size
3/17/2023
Date
4:15 PM
Time
776,157.00
Volume
214.61
Prev. Close
213.19
Open
25.14 B
Market Cap
117.20 M
Number of Shares
206.79
Day Low
213.19
Day High
208.49
185.15
52 Week Low
334.25
52 Week High
208.49
4.28
Dividend
1.90
Dividend Yield
9.89
P/E Ratio
99.80
Free Float in %
29.12
EPS 2023
98.99
Book Value per Share
21.68
Cash Flow per Share
Albemarle News More News
Albemarle Historical Prices
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Albemarle Analyst Data
Total Analysts: 59
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 80.00
Median: 279.29
Highest: 498.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Albemarle Analyst Opinions
- All
- Buy
- Hold
- Sell
02/21/23 | Oppenheimer & Co. Inc. | Maintained Buy | $498 | ||
02/21/23 | Piper Sandler | Maintained Buy | $330 | ||
02/17/23 | Oppenheimer & Co. Inc. | Maintained Buy | $498 | ||
02/17/23 | Mizuho | Maintained Hold | $328 | ||
02/17/23 | BMO Capital Markets | Maintained Buy | $325 | ||
02/16/23 | Credit Suisse | Maintained Sell | $240 | ||
01/31/23 | Credit Suisse | Maintained Sell | $240 | ||
01/26/23 | Mizuho | Maintained Hold | $325 | ||
01/26/23 | Piper Sandler | Maintained Buy | $310 | ||
01/25/23 | Deutsche Bank | Maintained Buy | $305 | ||
01/25/23 | Baird Patrick & Co | Maintained Hold | $305 | ||
01/25/23 | Oppenheimer & Co. Inc. | Maintained Buy | $497 | ||
01/12/23 | Mizuho | Maintained Hold | $300 | ||
01/11/23 | UBS | Maintained Hold | $250 | ||
12/15/22 | Citigroup Corp. | Maintained Buy | $295 | ||
11/28/22 | Morgan Stanley | Maintained Sell | $155 | ||
11/08/22 | RBC Capital Markets | Maintained Buy | $380 | ||
11/04/22 | Mizuho | Maintained Hold | $325 | ||
11/03/22 | Credit Suisse | Maintained Sell | $200 | ||
10/13/22 | Berenberg | Downgraded to Hold | $270 | ||
10/04/22 | Deutsche Bank | Maintained Buy | $305 | ||
10/03/22 | Bank of America Merrill Lynch | Maintained Hold | $332 | ||
09/09/22 | Citigroup Corp. | Maintained Buy | $345 | ||
09/08/22 | RBC Capital Markets | Maintained Buy | $371 | ||
08/08/22 | Oppenheimer & Co. Inc. | Maintained Buy | $440 | ||
08/04/22 | Credit Suisse | Maintained Sell | $196 | ||
08/04/22 | UBS | Maintained Hold | $265 | ||
06/27/22 | Credit Suisse | Maintained Sell | $185 | ||
06/02/22 | UBS | Downgraded to Hold | $260 | ||
05/24/22 | Deutsche Bank | Maintained Buy | $320 | ||
05/24/22 | RBC Capital Markets | Maintained Buy | $314 | ||
05/24/22 | Wells Fargo & Co | Maintained Buy | $320 | ||
05/12/22 | Wells Fargo & Co | Upgraded to Buy | $285 | ||
05/10/22 | RBC Capital Markets | Maintained Buy | $300 | ||
05/09/22 | Morgan Stanley | Maintained Sell | $135 | ||
05/06/22 | Deutsche Bank | Maintained Buy | $290 | ||
05/06/22 | Mizuho | Maintained Hold | $293 | ||
05/06/22 | Citigroup Corp. | Maintained Buy | $279 | ||
02/22/22 | RBC Capital Markets | Maintained Buy | $270 | ||
02/18/22 | Mizuho | Maintained Hold | $243 | ||
02/01/22 | Bank of America Merrill Lynch | Upgraded to Hold | |||
01/27/22 | HSBC | Upgraded to Buy | $280 | ||
12/15/21 | Goldman Sachs | Downgraded to Sell | $205 | ||
11/05/21 | Mizuho | Maintained Hold | $281 | ||
10/19/21 | RBC Capital Markets | Upgraded to Buy | $280 | ||
10/13/21 | Mizuho | Maintained Hold | $247 | ||
09/13/21 | Oppenheimer & Co. Inc. | Maintained Buy | $296 | ||
09/13/21 | Deutsche Bank | Maintained Buy | $270 | ||
09/13/21 | Wells Fargo & Co | Maintained Hold | $270 | ||
09/13/21 | BMO Capital Markets | Maintained Buy | $290 |
Albemarle Estimates* in USD
2023 | 2024 | 2025 | 2026 | |
---|---|---|---|---|
Revenue | 11,654 | 11,840 | 11,108 | 12,750 |
Dividend | 4.28 | 3.09 | 1.87 | - |
Dividend Yield (in %) | 1.90 % | 1.37 % | 0.83 % | 0.66 % |
EPS | 29.12 | 28.50 | 23.36 | 26.12 |
P/E Ratio | 7.24 | 7.39 | 9.02 | 8.07 |
EBIT | 3,698 | 3,619 | 3,337 | 4,504 |
EBITDA | 4,642 | 4,580 | 3,806 | 4,610 |
Net Profit | 3,388 | 3,293 | 2,680 | 3,105 |
Net Profit Adjusted | 3,376 | 3,257 | 2,610 | 3,105 |
Pre-Tax Profit | 3,738 | 3,683 | 3,166 | 4,413 |
Net Profit (Adjusted) | 3,856 | 3,410 | 3,321 | - |
EPS (Non-GAAP) ex. SOE | 29.12 | 28.50 | 23.36 | 26.12 |
EPS (GAAP) | 30.01 | 28.45 | 27.73 | 36.29 |
Gross Income | 4,933 | 4,791 | 3,686 | 4,468 |
Cash Flow from Investing | -1,664 | -1,900 | -2,557 | -2,913 |
Cash Flow from Operations | 2,721 | 3,318 | 3,183 | 3,220 |
Cash Flow from Financing | -152 | -210 | -225 | -110 |
Cash Flow per Share | 21.68 | 30.47 | 23.34 | - |
Free Cash Flow | 859 | 1,272 | 718 | 1,601 |
Free Cash Flow per Share | 3.60 | 10.66 | 9.05 | 8.39 |
Book Value per Share | 98.99 | 122.98 | 139.19 | 185.95 |
Net Debt | 1,084 | 219 | 920 | - |
Research & Development Exp. | 126 | 141 | 134 | 147 |
Capital Expenditure | 1,716 | 1,997 | 2,695 | 2,913 |
Selling, General & Admin. Exp. | 980 | 1,007 | 879 | 842 |
Shareholder’s Equity | 11,642 | 14,806 | 17,440 | 19,086 |
Total Assets | 18,948 | 22,373 | 26,105 | 30,221 |
Previous Quarter ending 12/31/22 |
Current Quarter ending 03/31/23 |
Next Quarter ending 06/30/23 |
Current Year ending 12/31/23 |
Next Year ending 12/31/24 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | 21 | 21 | 21 | 26 | 25 |
Average Estimate | 8.260 USD | 7.292 USD | 7.016 USD | 29.116 USD | 28.503 USD |
Year Ago | 1.010 USD | 2.380 USD | 3.450 USD | 21.960 USD | 29.116 USD |
Publish Date | 2/15/2023 | 5/3/2023 | 8/2/2023 | - | - |
Revenue Estimates | |||||
No. of Analysts | 17 | 16 | 16 | 26 | 24 |
Average Estimate | 2,621 USD | 2,755 USD | 2,826 USD | 11,654 USD | 11,840 USD |
Year Ago | 894 USD | 1,128 USD | 1,480 USD | 7,320 USD | 11,654 USD |
Publish Date | 2/15/2023 | 5/3/2023 | 8/2/2023 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Albemarle Insider Activity
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
Tozier Scott | 03/02/2023 | 5,700.00 | 69,503.00 | 251.40 | Sell | No |
Tozier Scott | 02/28/2023 | 417.00 | 75,203.00 | 255.49 | Sell | No |
NARWOLD KAREN G | 02/27/2023 | 1,502.00 | 15,013.00 | 254.31 | Sell | No |
NARWOLD KAREN G | 02/27/2023 | 1,502.00 | 13,155.00 | 254.31 | Sell | No |
NARWOLD KAREN G | 02/27/2023 | 751.00 | 11,297.00 | 254.31 | Sell | No |
Crawford Raphael Goszcz | 02/27/2023 | 1,323.00 | 22,117.00 | 254.31 | Sell | No |
Crawford Raphael Goszcz | 02/27/2023 | 1,323.00 | 20,080.00 | 254.31 | Sell | No |
Crawford Raphael Goszcz | 02/27/2023 | 662.00 | 18,043.00 | 254.31 | Sell | No |
Crawford Raphael Goszcz | 02/27/2023 | 3,607.00 | 17,025.00 | 254.31 | Sell | No |
Johnson Netha N. | 02/27/2023 | 1,502.00 | 23,614.00 | 254.31 | Sell | No |
Johnson Netha N. | 02/27/2023 | 1,502.00 | 21,756.00 | 254.31 | Sell | No |
Johnson Netha N. | 02/27/2023 | 751.00 | 19,898.00 | 254.31 | Sell | No |
Johnson Netha N. | 02/27/2023 | 4,097.00 | 18,969.00 | 254.31 | Sell | No |
Norris Eric | 02/27/2023 | 1,502.00 | 25,336.00 | 254.31 | Sell | No |
Norris Eric | 02/27/2023 | 1,502.00 | 23,478.00 | 254.31 | Sell | No |
Norris Eric | 02/27/2023 | 751.00 | 21,620.00 | 254.31 | Sell | No |
Norris Eric | 02/27/2023 | 1,366.00 | 20,691.00 | 254.31 | Sell | No |
Tozier Scott | 02/27/2023 | 1,502.00 | 75,620.00 | 254.31 | Sell | No |
Tozier Scott | 02/27/2023 | 1,502.00 | 73,762.00 | 254.31 | Sell | No |
Tozier Scott | 02/27/2023 | 751.00 | 71,904.00 | 254.31 | Sell | No |
Tozier Scott | 02/27/2023 | 5,462.00 | 70,975.00 | 254.31 | Sell | No |
Barichivich John Clarence III | 02/27/2023 | 160.00 | 4,743.00 | 254.31 | Sell | No |
Barichivich John Clarence III | 02/27/2023 | 160.00 | 4,367.00 | 254.31 | Sell | No |
Barichivich John Clarence III | 02/27/2023 | 159.00 | 3,991.00 | 254.31 | Sell | No |
NARWOLD KAREN G | 02/27/2023 | 3,360.00 | 16,515.00 | n/a | Buy | No |
Albemarle Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2022 | Albemarle Corp. | 1.58 | 0.73 | USD |
2021 | Albemarle Corp. | 1.56 | 0.67 | USD |
2020 | Albemarle Corp. | 1.54 | 1.04 | USD |
2019 | Albemarle Corp. | 1.47 | 2.01 | USD |
2018 | Albemarle Corp. | 1.34 | 1.74 | USD |
2017 | Albemarle Corp. | 1.28 | 1.00 | USD |
2016 | Albemarle Corp. | 1.22 | 1.42 | USD |
2015 | Albemarle Corp. | 1.16 | 2.07 | USD |
2014 | Albemarle Corp. | 1.10 | 1.83 | USD |
2013 | Albemarle Corp. | 0.96 | 1.51 | USD |
2012 | Albemarle Corp. | 0.80 | 1.29 | USD |
2011 | Albemarle Corp. | 0.67 | 1.30 | USD |
2010 | Albemarle Corp. | 0.56 | 1.00 | USD |
2009 | Albemarle Corp. | 0.50 | 1.37 | USD |
*Yield of the Respective Date
Albemarle Corp. Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 7.292 USD | Q1 2023 Earnings Release | 05/03/2023 |
Earnings Report | 7.016 USD | Q2 2023 Earnings Release | 08/02/2023 |
Earnings Report | - | Q3 2023 Earnings Release | 11/01/2023 |
Earnings Report | - | Q4 2023 Earnings Release | 02/14/2024 |
Albemarle Corp. Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Earnings Report | 8.620 USD | Q4 2022 Earnings Release | 02/15/2023 |
Press Conference | - | - | 08/04/2022 |
Press Conference | - | - | 05/05/2022 |
Shareholders' Meeting | - | - | 05/03/2022 |
Albemarle Profile
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following business segments: Lithium, Bromine, Catalysts, and All Other. The Lithium segment develops and manufactures basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine segment consists of bromine and bromine-based businesses including products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contains two product lines: clean fuel technologies, which are primarily composed of hydro processing catalysts, and heavy oil upgrading that is composed of fluidized catalytic cracking catalysts and additives. The All Other segment includes the FCS business. The company was founded in 1993 and is headquartered in Charlotte, NC.
Moody’s Daily Credit Risk Score
Albemarle Shareholder
Owner | in % |
---|---|
Freefloat | 99.80 |
Vanguard Group, Inc. (Subfiler) | 11.68 |
Capital Research & Management Co. (International Investors) | 6.53 |
SSgA Funds Management, Inc. | 4.56 |
State Street Corp. | 4.37 |
Vanguard Total Stock Market Index Fund | 3.08 |
BlackRock Fund Advisors | 2.94 |
Franklin Advisers, Inc. | 2.59 |
Vanguard Mid Cap Index Fund | 2.33 |
Vanguard 500 Index Fund | 2.32 |
Baillie Gifford & Co. | 2.31 |
BlackRock Institutional Trust Co. NA | 2.19 |
Capital Research & Management Co. (Global Investors) | 2.16 |
Geode Capital Management LLC | 2.02 |
Fidelity Management & Research Co. LLC | 1.77 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
Albemarle Management
Name | Job |
---|---|
Jerry Kent Masters | Chairman, President & Chief Executive Officer |
John C. Barichivich | Chief Accounting Officer, VP & Controller |
Karen Goldthwaite Narwold | Chief Administrative Officer & Executive VP |
Sean O'Hollaren | Chief External Affairs Officer |
Scott A. Tozier | Chief Financial Officer & Executive Vice President |
Melissa H. Anderson | Chief Human Resources Officer & Senior VP |
Glen Merfeld | Chief Technology Officer & VP-Energy Storage |
Holly Ann van Deursen | Independent Director |
Glenda J. Minor | Independent Director |
Diarmuid B. O'Connell | Independent Director |
Alejandro D. Wolff | Independent Director |
Ralf H. Cramer | Independent Director |
Mary Lauren Brlas | Independent Director |
Dean L. Seavers | Independent Director |
Gerald A. Steiner | Independent Director |
James J. O'Brien | Lead Independent Director |
Netha N. Johnson | President-Bromine Specialties |
Raphael Crawford | President-Catalysts |
Eric W. Norris | President-Lithium |
Kristin M. Coleman | Secretary, Executive VP & General Counsel |
Brook Wootton | Senior Director-Investor Relations |
Amy Dunbar | Treasurer & Vice President |
Meredith H. Bandy | VP-Investor Relations & Sustainability |